Table 3. Follow-up data.

Follow-up data	n=95 patients
Follow-up length, days	96 [range 49-526]
Imaging modality used during follow-up
2D/3D transoesophageal echocardiography	93 (97.9%)
Cardiac computed tomography	2 (2.1%)
Device-related thrombus at the initial LAA device	1 (1.1%)
Persistent peri-device leakage	18 (18.9%)
Maximum diameter, mm	2.5±1.3
Leak 0-3 mm	13 (72.2%)
Leak 3-5 mm	5 (27.8%)
Leak >5 mm	0
Transitory ischaemic attack	3 (3.2%)
MACE overall	5 (5.3%)
Ischaemic stroke	2 (2.1%)
Systemic embolism	0
Bleeding complications ≥ BARC type 2	3 (3.2%)
Device embolisation	0
Death	2 (2.2%)
Cardiovascular	1 (1.1%)
Unknown	1 (1.1%)
BARC: Bleeding Academic Research Consortium; MACE: major adverse cardiovascular events